Anemia Drugs Linked to Stroke Study Deaths: FDA

This is just another issue with these drugs. They need to be used appropriately in all patients that may be candidates for their use.

The anemia drug erythropoietin and its congeners have been used extensively in patients with renal failure and in patients with cancer to boost the red cell count. However, erythropoietin also helps reduce programmed cellular death and is involved in the growth of new vessels. Because of these features it was always considered an attractive therapy for patients with heart attacks or strokes. Unfortunately,...